Latest debt-to-equity ratio
Kymera Therapeutics Debt-to-equity ratio
Direct answer
Kymera Therapeutics's debt-to-equity ratio is 5.21%.
The verified market snapshot reports 5.21%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Kymera Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 5.21%
Explore related company data
View Kymera Therapeutics's market capitalizationView Kymera Therapeutics's price-to-book ratioView Kymera Therapeutics's return on equityView Kymera Therapeutics's dividend yieldView Kymera Therapeutics's 52-week price rangeView Kymera Therapeutics's revenue growthView Kymera Therapeutics's profit marginView all Kymera Therapeutics key metricsReturn to Kymera Therapeutics profile